Listed

HealthLynked Corp: Form 10-Q for the period ended Mar 31, 2023

Filed with the SEC on May 15, 2023 and accepted by EDGAR at May 15, 2023, 16:00 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2023-01-01 to 2023-03-31$16.3kus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Selling, general and administrative3 months2023-01-01 to 2023-03-31$1.1mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2023-01-01 to 2023-03-31−$1.1mus-gaap:OperatingIncomeLoss
Interest expense3 months2023-01-01 to 2023-03-31$11.4kus-gaap:InterestExpense
Net income3 months2023-01-01 to 2023-03-31$1.5mus-gaap:NetIncomeLoss
Basic EPS3 months2023-01-01 to 2023-03-31$0.00us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2023-01-01 to 2023-03-31257,131,222 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2023-01-01 to 2023-03-31−$1.1mus-gaap:NetCashProvidedByUsedInOperatingActivities
Current assetsAt period end2023-03-31$2.2mus-gaap:AssetsCurrent
Total assetsAt period end2023-03-31$6.1mus-gaap:Assets
Current liabilitiesAt period end2023-03-31$3.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2023-03-31$4.0mus-gaap:Liabilities
Long-term debtAt period end2023-03-31$37.5kus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2023-03-31$2.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001213900-23-039725. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.